ArticleClinical cardiology2017

Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort.

Jessie Kittle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.